ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

The Role of JAK2 Inhibition in Patients With PV

John Mascarenhas, MD
Published Online:6:25 PM, Mon December 4, 2017

John Mascarenhas, MD, associate professor, Icahn School of Medicine at Mount Sinai, discusses the role of JAK2 inhibition in patients with polycythemia vera (PV).
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.